Alvine Pharmaceuticals

Read more
Abhay Joshi's photo - President & CEO of Alvine Pharmaceuticals

President & CEO

Abhay Joshi

CEO Approval Rating

73/100

Founded:

2005

Status:

Est. Annual Revenue
$8.5M
Agree?
Est. Employees
35
Agree?

ALVINE PHARMACEUTICALS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Alvine Pharmaceuticals's company profile
Abhay Joshi's photo - President & CEO of Alvine Pharmaceuticals

Abhay Joshi

President & CEO

73/100
35
$108.5M
$8.5M
View Profile
1
Alvine Pharmaceuticals's Competitor - Opsona logo
Martin Welschof's photo - CEO of Opsona

Martin Welschof

CEO

74/100
25
$59.6M
$6.3M
View Profile
2
Alvine Pharmaceuticals's Competitor - ChemoCentryx logo
Thomas J. Schall's photo - Chairman & CEO of ChemoCentryx

Thomas J. Schall

Chairman & CEO

89/100
76
$679.3M
$21.6M
View Profile
3
Alvine Pharmaceuticals's Competitor - Inovio logo
Joseph J. Kim's photo - President & CEO of Inovio

Joseph J. Kim

President & CEO

69/100
281
$296.4M
$6.5M
View Profile
4
Alvine Pharmaceuticals's Competitor - Medexus Pharma, Inc. logo
CEO Avatar

CEO

- -
55
- -
$3.4M
View Profile
5
Alvine Pharmaceuticals's Competitor - Jounce logo
Richard Murray's photo - President & CEO of Jounce

Richard Murray

President & CEO

79/100
115
$296.1M
$89.2M
View Profile
6
Alvine Pharmaceuticals's Competitor - Agenus logo
Garo H. Armen's photo - Chairman & CEO of Agenus

Garo H. Armen

Chairman & CEO

81/100
294
$352.2M
$68.5M
View Profile
7
Alvine Pharmaceuticals's Competitor - Achaogen logo
Blake Wise's photo - CEO of Achaogen

Blake Wise

CEO

77/100
42
$221.4M
$ < 1M
View Profile
8
Alvine Pharmaceuticals's Competitor - Baliopharm logo
Andreas Herrmann's photo - Founder & CEO of Baliopharm

Andreas Herrmann

Founder & CEO

84/100
18
- -
$2.9M
View Profile
9
Alvine Pharmaceuticals's Competitor - Kineta logo
Shawn Iadonato's photo - Co-Founder & CEO of Kineta

Shawn Iadonato

Co-Founder & CEO

94/100
150
$86.4M
$12M
View Profile
10
Alvine Pharmaceuticals's Competitor - Merrimack Pharmaceuticals Inc logo
CEO Avatar

CEO

- -
27
$322.5M
$25.9M
View Profile
11
Alvine Pharmaceuticals's Competitor - Zynerba logo
Armando Anido's photo - Chairman & CEO of Zynerba

Armando Anido

Chairman & CEO

84/100
25
$55M
$ < 1M
View Profile
12
Alvine Pharmaceuticals's Competitor - Immune Design logo
Carlos Paya's photo - President & CEO of Immune Design

Carlos Paya

President & CEO

83/100
48
$160.5M
$2.2M
View Profile

Missing a competitor? Contribute!

Opsona is the top competitor of Alvine Pharmaceuticals. Opsona is a Private company that was founded in Dublin, County Dublin in 2004. Opsona operates in the Biotechnology industry. Opsona has 10 fewer employees vs. Alvine Pharmaceuticals.

ChemoCentryx is seen as one of Alvine Pharmaceuticals's biggest rivals. ChemoCentryx was founded in San Carlos, California} in 1997. Like Alvine Pharmaceuticals, ChemoCentryx also operates in the Pharmaceuticals sector. Compared to Alvine Pharmaceuticals, ChemoCentryx generates $13.1M more revenue.

Inovio is perceived as one of Alvine Pharmaceuticals's biggest rivals. Inovio was founded in 1979, and is headquartered in Plymouth Meeting, Pennsylvania. Like Alvine Pharmaceuticals, Inovio also competes in the Pharmaceuticals space. Inovio generates $2M less revenue vs. Alvine Pharmaceuticals.

Alvine Pharmaceuticals Acquisitions

No recent acquisitions found related to Alvine Pharmaceuticals

Alvine Pharmaceuticals Funding History

Since Alvine Pharmaceuticals was founded in 2005, it has participated in 4 rounds of funding. In total Alvine Pharmaceuticals has raised $108.5M. Alvine Pharmaceuticals' last funding round was on May 2013 for a total of $70.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Unattributed
May 2013
$70M
Debt
Dec 2012
$6M
-
Debt
Oct 2011
$6M
-
Series A
Sep 2009
$26.5M

Since Alvine Pharmaceuticals was founded in 2005, it has participated in 4 rounds of funding. In total Alvine Pharmaceuticals has raised $108.5M. Alvine Pharmaceuticals' last funding round was on May 2013 for a total of $70.0M

Alvine Pharmaceuticals Investments

No recent investments found related to Alvine Pharmaceuticals

Alvine Pharmaceuticals News

Alvine Pharmaceuticals Press Releases

March 7, 2016MarketersMedia

Clinical Trials of Celiac Disease Market Global Reviewed for H1 2016

ReportsnReports adds Celiac Disease Market research to its database.... See more »
March 3, 2016Business Wire

ImmusanT, Alba Therapeutics, Alvine Pharmaceuticals - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/v2387j/celi... See more »
September 29, 2015PR-INSIDE.COM

Alvine Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

(PR-inside.com) Alvine Pharmaceuticals, Inc. (Alvine) is a biopharmaceutical company. The company dev... See more »
July 27, 2015BUSINESS WIRE

Celiac Disease Clinical Trials - Global Review, H1, 2015

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8379k9/celi... See more »
June 10, 2015BUSINESS WIRE

Global Celiac Disease Pipeline Review, H1 2015 - 10 Companies & 20 Drug Profiles

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/p8fhcx/celi... See more »
May 14, 2015BRIEFINGWIRE

Alvine Pharmaceuticals, Inc. - Product Pipeline Review - 2014 According To Radiant Insights

RadiantInsights.com includes new market research report on "Alvine Pharmaceuticals, Inc. - Product Pi... See more »
May 12, 2015PR-INSIDE.COM

Alvine Pharmaceuticals, Inc. - Product Pipeline Review - 2015 - New Study Released

(PR-inside.com) Global Markets Direct's, 'Alvine Pharmaceuticals, Inc. - Product Pipeline Review - 20... See more »

Social Media

Alvine Pharmaceuticals Headquarters

75 Shoreway Rd Suite B

San Carlos, California94070

650-632-1645

Driving Directions »

Trending Companies

Alvine Pharmaceuticals Summary

ABOUT

Overview

Alvine Pharmaceuticals develops novel therapies for autoimmune diseases. Alvine Pharmaceuticals was founded in 2005. Alvine Pharmaceuticals' headquarters is located in San Carlos, California, USA 94070. It has raised 108.5M in 4 rounds. The latest rou...

CEO

Alvine Pharmaceuticals's President & CEO, Abhay Joshi, currently has an approval rating of 73%. Alvine Pharmaceuticals's primary competitors are Opsona, ChemoCentryx & Inovio.

Frequently Asked Questions about Alvine Pharmaceuticals

  1. When was Alvine Pharmaceuticals founded?

    Alvine Pharmaceuticals was founded in 2005
  2. Who is Alvine Pharmaceuticals's CEO?

    Alvine Pharmaceuticals's CEO is Abhay Joshi
  3. How much revenue does Alvine Pharmaceuticals generate?

    Alvine Pharmaceuticals generates $8.5M in revenue
  4. How much funding does Alvine Pharmaceuticals have?

    Alvine Pharmaceuticals has historically raised $108.5M in funding
  1. Where is Alvine Pharmaceuticals's headquarters?

    Alvine Pharmaceuticals's headquarters is in San Carlos California, USA
  2. How many employees does Alvine Pharmaceuticals have?

    Alvine Pharmaceuticals has 35 employees
  3. What sector does Alvine Pharmaceuticals operate in?

    Alvine Pharmaceuticals is in Pharmaceuticals
  4. Who are Alvine Pharmaceuticals's competitors?

    Alvine Pharmaceuticals's top competitors are Opsona, ChemoCentryx, Inovio